Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
NBO is a nonpharmacological measure of neuroprotection. The purpose of our study is to evaluate the safety and efficiency of NBO(Normobaric hyperoxia) in the acute ischemic stroke patients who received endovascular treatment. Looking for more clinical evidence for the ischemic stroke patients who will be treated with NBO in the future.
Epistemonikos ID: d5f7a1afc37df262f4b073e618e42d8532bab7c1
First added on: May 21, 2024